Dehydro Clindamycin
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1440605-51-5Dehydro Clindamycin

● In Stock

Catalogue No.:VE009161
CAS No.:1440605-51-5
Mol. Formula:C18H31ClN2O5S
Mol. Weight:422.97 g/mol

Additional information on CAS 1440605-51-5

Parent drug

Clindamycin

IUPAC Name

Methyl 7-Chloro-6, 7, 8-trideoxy-6-[[[(2S)-1-methyl-4-propylidene-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside

Synonyms

N/A

Description

Dehydro Clindamycin (CAS No.1440605-51-5) is an impurity present in Clindamycin, Clindamycin is a semi-synthetic lincosamide antibiotic, It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli, clindamycin appears to carry some activity against protozoans, which is used in the treatment of toxoplasmosis, malaria, and babesiosis.

References

Smieja, M. (1998). Current Indications for the Use of Clindamycin: A Critical Review. Canadian Journal of Infectious Diseases, 9(1), 22–28. https://doi.org/10.1155/1998/538090

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url